Did I think too much?
Release time:
2020-08-14
Is it because I think too much?
Recently, I heard a joke: "When I was a child, I was always struggling with a question: Should I go to Tsinghua University or Peking University? When I grew up, I found that I think too much!" After laughing, I always feel a little sour. Who didn't have a dream when we were young? Is this really a joke?
What is a dream? It is our beautiful wish for the future, which is better than reality and better than fantasy reality. From childhood to adulthood, many times I was asked "what do I want to do when I grow up", and even the school composition would be asked to write "my dream". Before, my dream is changeable. Yesterday, after watching the soldiers on the news fighting for disaster relief, I wanted to be a soldier; today, I saw the doctors in the TV series saving lives and healing the wounded, and I want to be a doctor; tomorrow, I am full of curiosity about the Fenjin Dingxue, and I want to be a touch again. Jin captain. However, as I grow older, I understand that dreams cannot be replaced at random. It is a person's goal. If you change at will, isn't the previous struggle equal to zero? Not all dreams are realized in a day or two, it requires hard work and patient waiting. Dreams are beautiful when they come true, but behind the beauty is often hard and rough. This is what we often say "dream is very full, reality is very skinny".
On a whim, she asked her four-year-old daughter, "What is your dream?" She answered without thinking, "Go to Tsinghua and Peking University!" "Is that going to Tsinghua University or Peking University?" After a serious silence of ten seconds, she replied, "Going to Tsinghua University and Peking University!" In the children's consciousness, they may not know what Peking University in Tsinghua is, but they already have dreams. As a mother, I will encourage her, because although the dream will change when she grows up, she will work hard and wait patiently, but she will persevere!
A beautiful dream is like a path to success, but the roadside is full of thorns. When the dream is about to die, it may be only a few steps away from success, and the hard work on the road will always be fruitful.
Even if it is a joke, what's wrong with thinking more about it! (Xu Yuting)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31